About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rev3ltm1Rwd
targeted mutation 1, Richard D Wood
MGI:2386322
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Rev3ltm1Rwd/Rev3ltm1Rwd involves: 129P2/OlaHsd MGI:3617649
cn2
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53tm1Brd
Tg(MMTV-cre)1Mam/0
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N MGI:4441274
cn3
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)1Mam/0
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N MGI:4441276
cn4
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Tg(MMTV-cre)1Mam/0
involves: 129P2/OlaHsd * C57BL/6 * FVB MGI:4441273


Genotype
MGI:3617649
hm1
Allelic
Composition
Rev3ltm1Rwd/Rev3ltm1Rwd
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rev3ltm1Rwd mutation (0 available); any Rev3l mutation (120 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• surprisingly, homozygous mutant embryos die at mid-gestation, exhibiting a significant decline in Mendelian frequency between E9.5 and E12.5
• attempts to generate homozygous mutant ES cells and embryonic fibroblasts from mid-gestation embryos have been unsuccessful

embryo
• mutant embryos show reduced branching of blood vessels in the yolk sac
• mutant embryos fail to turn by E9.5; however, some mutants are able to complete axial rotation by E10.5
• at E9.5-E12.5, homozygous mutant embryos display a developmental delay of up to 2 days relative to wild-type embryos
• starting at E8.5, homozygous mutant embryos appear smaller than their heterozygous and wild-type counterparts
• at E9.5-E12.5, homozygous mutant embryos are ~60% of wild-type length
• at E10.5, mutant embryos display a highly disorganized and degenerated mesenchyme, with pyknotic bodies and debris detected throughout the tissue
• epithelial and neuroepithelial cell pleiomorphism is commonly observed
• at E10.5, mutant embryos display degeneration of neural tube tissue
• at E9.5 and E10.5, homozygous mutant somites display a diffuse, aberrant structure
• at E9.5 and E10.5, homozygous mutant embryos have decreased numbers of somite pairs relative to heterozygous embryos
• mutant yolk sacs are often fragile, with loose attachment of the embryo to the decidual implantation site, possibly due delayed and/or inadequate chorioallantoic fusion

nervous system
• epithelial and neuroepithelial cell pleiomorphism is commonly observed
• at E10.5, mutant embryos display degeneration of neural tube tissue

cardiovascular system
• mutant embryos show reduced branching of blood vessels in the yolk sac
• at E10.5 or later, mutant embryos exhibit pericardial sac edema

cellular
• homozygous mutant embryos display widespread degeneration and cell death

craniofacial

homeostasis/metabolism
• at E10.5 or later, mutant embryos exhibit pericardial sac edema

growth/size/body
• at E9.5-E12.5, homozygous mutant embryos display a developmental delay of up to 2 days relative to wild-type embryos
• starting at E8.5, homozygous mutant embryos appear smaller than their heterozygous and wild-type counterparts
• at E9.5-E12.5, homozygous mutant embryos are ~60% of wild-type length




Genotype
MGI:4441274
cn2
Allelic
Composition
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53tm1Brd
Tg(MMTV-cre)1Mam/0
Genetic
Background
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rev3ltm1Rwd mutation (0 available); any Rev3l mutation (120 available)
Rev3ltm2.1Rwd mutation (2 available); any Rev3l mutation (120 available)
Tg(MMTV-cre)1Mam mutation (1 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (240 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mean survival is 91 days compared with 134 to 117 days for Trp53tm1Brd homozygous control mice

neoplasm
• in all mice develop thymic lymphomas compared with 70% to 77% of Trp53tm1Brd homozygous control mice
• tumors are frequently oligoclonal
• incidence of thymic lymphomas is increased while latency to development of tumors is decreased compared with Trp53tm1Brd homozygous control mice

endocrine/exocrine glands
• in all mice develop thymic lymphomas compared with 70% to 77% of Trp53tm1Brd homozygous control mice
• tumors are frequently oligoclonal
• incidence of thymic lymphomas is increased while latency to development of tumors is decreased compared with Trp53tm1Brd homozygous control mice

immune system
• in all mice develop thymic lymphomas compared with 70% to 77% of Trp53tm1Brd homozygous control mice
• tumors are frequently oligoclonal
• incidence of thymic lymphomas is increased while latency to development of tumors is decreased compared with Trp53tm1Brd homozygous control mice

hematopoietic system
• in all mice develop thymic lymphomas compared with 70% to 77% of Trp53tm1Brd homozygous control mice
• tumors are frequently oligoclonal
• incidence of thymic lymphomas is increased while latency to development of tumors is decreased compared with Trp53tm1Brd homozygous control mice




Genotype
MGI:4441276
cn3
Allelic
Composition
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)1Mam/0
Genetic
Background
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rev3ltm1Rwd mutation (0 available); any Rev3l mutation (120 available)
Rev3ltm2.1Rwd mutation (2 available); any Rev3l mutation (120 available)
Tg(MMTV-cre)1Mam mutation (1 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (240 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 11 of 36 mice develop mammary tumors consisting of solid carcinoma, carcinosarcoma, adenosquamous carcinoma, and osteosarcoma
• incidence of mammary tumors is increased while latency to development of tumors is decreased compared with Trp53tm1Brd heterozygotes
• in the mammary tissue of some mice
• in the mammary tissue of one mouse

integument
• 11 of 36 mice develop mammary tumors consisting of solid carcinoma, carcinosarcoma, adenosquamous carcinoma, and osteosarcoma
• incidence of mammary tumors is increased while latency to development of tumors is decreased compared with Trp53tm1Brd heterozygotes

skeleton
• in the mammary tissue of one mouse

endocrine/exocrine glands
• 11 of 36 mice develop mammary tumors consisting of solid carcinoma, carcinosarcoma, adenosquamous carcinoma, and osteosarcoma
• incidence of mammary tumors is increased while latency to development of tumors is decreased compared with Trp53tm1Brd heterozygotes




Genotype
MGI:4441273
cn4
Allelic
Composition
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Tg(MMTV-cre)1Mam/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rev3ltm1Rwd mutation (0 available); any Rev3l mutation (120 available)
Rev3ltm2.1Rwd mutation (2 available); any Rev3l mutation (120 available)
Tg(MMTV-cre)1Mam mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 6 of 24 mice develop mammary tumors consisting of carcinosarcoma, solid carcinoma, and adenosquamous carcinoma
• in the mammary tissue of some mice

integument
• 6 of 24 mice develop mammary tumors consisting of carcinosarcoma, solid carcinoma, and adenosquamous carcinoma

endocrine/exocrine glands
• 6 of 24 mice develop mammary tumors consisting of carcinosarcoma, solid carcinoma, and adenosquamous carcinoma





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory